Headlines

Promising New Treatment Emerges for ‘Frustrating’ Eye Disease

Published

8 years ago

November 10, 2016

It can “potentially alter the course of this dreaded disease.”

A new study suggests that corneal crosslinking is a promising treatment for adolescent patients who have keratoconus, the American Optometric Association reports.

Keratoconus is a progressive condition can cause the cornea to thin and bulge out to form a cone shape.

Traditionally, in adults, corneal transplants have been considered the last, best option for keratoconus patients. This treatment has been discouraged in adolescents because of keratoconus aggressiveness and the tendency for younger patients to rub their eyes, according to AOA.

Corneal crosslinking is a less invasive option that was approved in April by the U.S. Food & Drug Administration. It involves applying ultraviolet light along with a riboflavin agent to the cornea, preventing further progression of the disease, the AOA explains.

A new study published in the European Journal of Ophthalmology found the treatment to be effective in young patients. The study was small, involving 19 patients who were 18 years old or younger.

One optometrist, Dr. Michael DePaolis of Rochester, NY, was quoted by AOA saying he’s “excited about the results” of the Turkish study.

“From my perspective, I’ve watched so many people go through the throes of keratoconus,” he said. “If I could wave a magic wand over one eye disease and halt it in its tracks, it would be — aside from age-related macular degeneration — keratoconus.” He’s seen many patients suffer from symptoms such as blurred vision, light sensitivity and discomfort.

He added: “Finally, we have a treatment option that can potentially alter the course of this dreaded disease.”

Read more at AOA

With Crizal you can have it all!

Patients expect clarity of vision, scratch resistance, anti-glare technology, easy-to-clean lenses, and UV protection from their lenses. Crizal Sapphire HR is the latest generation of anti-reflective coating that combines our innovative technologies, 360 Multi-angular Technology™, High-Resistance Technology™, High Surface Density Process™ into one coating to deliver best in class performance. Your patients’ main concerns of anti-glare, scratch resistance, and easiness to clean are covered. Crizal Sapphire HR shield the lenses against reflections, scratching, smudging and UV light for long-lasting transparency, durability, and protection. Crizal coatings can be applied to any design, including traditional single vision, Eyezen®, Eyezen+ and Varilux®! Widely available across lab networks and through all major managed vision care providers today. Crizal Saphire HR benefits include: • 360 Multi-angular Technology™ that cuts front and lateral backside reflection • High-Resistance Technology™ that offers the best combination of scratch and smudge resistance • High Surface Density Process™ that ensures the lense is easy-to-clean, smudge resistant and water repellent For more information about Crizal Saphire HR, go here.